Geron Corporation (Nasdaq: GERN) has announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include RYTELO™ (imetelstat) as a recommended treatment for symptomatic anemia…
The Althaia Foundation is launching an innovative project to prevent falls in frail hospitalized patients using artificial intelligence. In collaboration with Robbie AI, this initiative aims to help healthcare professionals…
Merck (NYSE: MRK), known as MSD outside the U.S. and Canada, has announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has issued a positive…
Flosonics Medical, a leader in wearable medical ultrasound, today announced that Sutter Health, an integrated not-for-profit system based in Northern California, will implement FloPatch, the world’s first wireless, wearable Doppler…
Jaan Health, a prominent provider of chronic care management and proactive healthcare solutions, has announced a strategic partnership with NeuroNet, a national organization dedicated to advancing community neurology practices. NeuroNet…
GenSight Biologics (Euronext: SIGHT, ISIN: FR0013183985, PEA-PME eligible), a biopharmaceutical company specializing in innovative gene therapies for retinal neurodegenerative diseases and central nervous system disorders, has announced its cash position…
Health Net, a prominent Medi-Cal managed care health plan in California and part of Centene Corporation, announced today its recognition as one of “America’s Greatest Workplaces for LGBTQ+ 2024” by…
Researchers have made a groundbreaking advance in cancer treatment by successfully using Seraph® 100 blood filtration media to remove Circulating Tumor Cells (CTCs) from patients with advanced pancreatic cancer. This…
Crescita Therapeutics Inc. (TSX: CTX and OTC US: CRRTF), a Canadian commercial dermatology company focused on growth and innovation, has announced the signing of an exclusive Manufacturing and Supply Agreement…
Lynch Regenerative Medicine, LLC (LRM) has successfully concluded its Series A financing to advance innovative skin rejuvenation and regeneration solutions based on FDA-approved pure platelet-derived growth factor (PDGF). Champion VC,…
MedImpact Healthcare Systems, Inc., the nation’s largest independent provider of health solutions, technology, and pharmacy benefit management services, has announced the successful completion of the integration of Elixir Solutions. This…
Sensorion (FR0012596468 – ALSEN), a pioneering biotechnology company specializing in hearing loss disorders, has unveiled new positive findings from its SENS-401 Phase 2a clinical trial. The data, focusing on the…